Ozempic Is Killing Off Weight Loss Surgeries. That's a Problem

The rise of Ozempic, a medication for diabetes that promotes weight loss, is leading to a decline in weight loss surgeries, raising concerns among healthcare professionals. As more patients opt for this drug over surgical options, there are implications for the future of obesity treatment and healthcare practices. The shift could affect the availability and funding for surgical interventions, highlighting a need for a balanced approach to obesity management.